Clinical trials of Covid vaccine set to start at Bhubaneswar from Wednesday: Official
Monday, 20 July 2020 () Human clinical trials of the country's indigenously developed Covid-19 vaccine is set to begin this week at a Bhubaneswar-based institute -- one of the 12 centres selected by the ICMR for conducting phase one and two of the process, a senior official said.
Human trials of a Covid vaccine candidate, developed in India, have begun. Trials of the drug named Covaxin are being conducted at PGIMS, Rohtak. Bharat Biotech and ICMR's National Institute of Virology, Pune developed Covaxin. The other trial vaccine developed in India is Zydus Cadila's ZyCov-D. The...
The Union Health Ministry on August 04 briefed the media in Delhi, over the current COVID-19 situation in nation. Speaking in press conference, Ministry of Health, Secretary, Rajesh Bhushan stated that more than 6.6 lakh COVID-19 tests have been conducted in last 24 hours in the nation. Adding on it, he said recovered cases are now double of the active cases in India. He said, "More than 2 crore COVID-19 tests have been conducted, including more than 6.6 lakh tests in the last 24 hours. Recovered cases are now double of the active cases. The case fatality rate is lowest since the first lockdown."
Delhi Health Minister Satyendar Jain informed that Delhi has slipped on the table of COVID-19 active cases. "Earlier it was on second position and now it is on the fourteen position in terms of active cases," Satyendar Jain said. On serological survey, he said, "We will have to extend the serological survey in Delhi by 2 more days. Around 15,000 samples will be collected during the survey."
Bhubaneswar is currently under COVID-19 lockdown. Police officials were seen checking vehicular traffic movement at the check-posts. Lockdown was imposed after tally of active cases jumped in Bhubaneswar and to curb spread of coronavirus.
Director General of Indian Council of Medical Research, Dr Balram Bhargava on August 04 stated that Oxford vaccine, being manufactured by Serum Institute of India, got approval for phase 2 and 3 clinical trials which are starting within a week at 17 sites. Earlier, the Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford vaccine.
India reported a single-day spike of 52,050 in last 24 hours taking the country's tally to 18,55,746. So far, the country has 5, 86, 298 active cases. With 803 new deaths, the death toll rises to 38938 deaths. The Indian Council of Medical Research reported the total number of COVID-19 samples tested up to 3rd August is 2,08,64,750. 6,61,182 samples were tested on August 03.
Mumbai Mayor Kishori Pednekar on IPS officer Vinay Tiwari put under quarantine by BMC officials stated that guidelines by WHO and ICMR are same for all. "WHO and ICMR guidelines and SOPs are same for all. No one is forced into anything. People can be quarantined either at hotels or placed in home quarantine. SOP was followed. I think it was not forced," said Mumbai Mayor Kishori Pednekar. Patna SP arrived in Mumbai to join Sushant's death case probe.
Number of COVID-19 tests crosses the 2 crore mark in India. 2,02,02,858 tests have been conducted till August 2. According to the Indian Council of Medical Research, 3,81,027 tests were conducted on August 2. Along with this, India reported single day spike of 52,972 COVID positive cases in the last 24 hours. India's COVID-19 tally has risen to 18,03,696 including 5,79,357active cases. Over 1 crore people have been cured from the virus so far, toll reaches 1,186,203.
The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford University. According to the World Health..